EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Targeting the neuro-immune crosstalk in breast cancer brain metastases

Yutian Zou, Jiadi Wu, Ze Yuan, Xiaofang He, Hailin Tang

Journal for ImmunoTherapy of Cancer · 2026-04 · 14 (4) · e014134

DOI: 10.1136/jitc-2025-014134 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 02.04.2026. Verfasst von Yutian Zou und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Brain Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer brain metastasis (BCBrM) remains one of the most lethal manifestations of breast cancer. Its response to immunotherapy is severely limited by the blood-brain barrier, which restricts immune cell infiltration and antigen presentation, thereby creating an immunosuppressive microenvironment. To overcome these barriers, recent studies have focused on novel immune checkpoints, including the Lymphocyte-Activated Gene 3–Galectin 3 (LAG3–LGALS3) and T-Cell Immunoreceptor with Ig and ITIM Domains–Nectin Cell Adhesion Molecule 2 (TIGIT–NECTIN2) axes, as well as on the reprogrammed metastatic ecosystem driven by immunosuppressive cells such as Forkhead Box P3-positive (FOXP3⁺) Regulatory T (Treg) cells, Lysosomal-Associated Membrane Protein 3-positive (LAMP3⁺) tolerogenic dendritic cells (DCs), C-C Motif Chemokine Ligand 18-positive (CCL18⁺) M2-like macrophages, Regulator of G-Protein Signaling 5-positive (RGS5⁺) cancer-associated fibroblasts (CAFs), Galectin 1-positive (LGALS1⁺) and TANK-Binding Kinase 1-positive (TBK1⁺) microglia, and phosphorylated Signal Transducer and Activator of Transcription 3-positive (pSTAT3⁺) reactive astrocytes. In addition, targeted inhibition of tumor-derived N-acetyltransferase 8-like (NAT8L) and metabolites N-Acetylaspartate (NAA), suppression of the N-Methyl-D-Aspartate Receptor (NMDAR) signaling pathway in tumor cells, and interventions against γ-Aminobutyric Acid (GABA)ergic reprogramming in BCBrM cells. Moreover, targeted interventions against distinct immune escape pathways—such as the Ubiquitin-Conjugating Enzyme E2T (UBE2T)/Cell Division Cycle 42 (CDC42)/Cluster of Differentiation 276 (CD276) and C-C Motif Chemokine Ligand 2–C-C Motif Chemokine Receptor 2/C-C Motif Chemokine Receptor 4 (CCL2–CCR2/CCR4) axes—have shown promise in reshaping the immune microenvironment and enhancing the efficacy of conventional immunotherapy. Collectively, this perspective outlines evolving strategies in immune checkpoint modulation, cellular ecosystem reprogramming, and neuroimmune intervention, providing a forward-looking framework to enhance the efficacy of immunotherapy in BCBrM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsBreast NeoplasmsHumansFemaleAnimalsTumor Microenvironment

Stichwörter der Autor:innen

Breast CancerImmune Checkpoint InhibitorImmunosuppressionImmunotherapyTumor microenvironment - TME

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Guangzhou Institute of Cancer Research, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, China.
  • Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China tanghl@sysucc.org.cn hexf28@mail.sysu.edu.cn.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China tanghl@sysucc.org.cn hexf28@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zou, Y., Wu, J., Yuan, Z., He, X., & Tang, H. (2026). Targeting the neuro-immune crosstalk in breast cancer brain metastases. Journal for ImmunoTherapy of Cancer, 14(4), e014134. https://doi.org/10.1136/jitc-2025-014134

Vancouver

Zou Y, Wu J, Yuan Z, He X, Tang H. Targeting the neuro-immune crosstalk in breast cancer brain metastases. Journal for ImmunoTherapy of Cancer. 2026;14(4):e014134. doi:10.1136/jitc-2025-014134

BibTeX
@article{Zou2026,
  author = {Zou, Yutian and Wu, Jiadi and Yuan, Ze and He, Xiaofang and Tang, Hailin},
  title = {Targeting the neuro-immune crosstalk in breast cancer brain metastases},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {e014134},
  doi = {10.1136/jitc-2025-014134}
}
Kostenlos starten →